Disclosure Of Interests In Other Entities [Text Block]

GenSight Biologics S.A. - Filing #855040

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	22,947,000 EUR	—	—	—	53,363,000 EUR	—	—	—	—
Non-current assets	2,994,000 EUR	—	—	—	3,285,000 EUR	—	—	—	—
Current liabilities	14,642,000 EUR	—	—	—	22,242,000 EUR	—	—	—	—
Non-current liabilities	26,577,000 EUR	—	—	—	18,417,000 EUR	—	—	—	—
Profit (loss)	—	—	27,625,000 EUR	27,625,000 EUR	—	—	28,617,000 EUR	28,617,000 EUR	—
Comprehensive income	—	124,000 EUR	27,625,000 EUR	27,748,000 EUR	—	207,000 EUR	28,617,000 EUR	28,824,000 EUR	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	10,610,000 EUR	—	—	—	44,288,000 EUR	—	—	—	37,943,000 EUR
Tax expense (income)	—	—	—	5,000 EUR	—	—	—	2,000 EUR	—